Targeted Screening for Taenia Solium Tapeworms

Oregon Health & Science University (OHSU)

Status: Completed

Conditions: Taenia Solium Taeniasis

Treatments: Drug: Niclosamide; Behavioral: Community education campaign

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT01296958

1R21NS069275-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to determine whether screening and treatment of tapeworm carriers can decrease community transmission of Taenia solium parasitic infection.

Enrollment: 1,811 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• All community members are eligible

Exclusion criteria

• Inability to provide informed consent

Trial design

Primary purpose: Screening

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

1,811 participants in 2 patient groups

Targeted screening

Experimental group

Description:

Screening for intestinal tapeworm carrier followed by treatment with niclosamide as indicated.

Treatment:

Drug: Niclosamide

Education

Active Comparator group

Description:

Community education about Taenia solium prevention.

Treatment:

Behavioral: Community education campaign